Cipla and DNDi launch child-friendly 4-in-1 antiretroviral treatment HIVPress Releases Cipla and DNDi launch child-friendly 4-in-1 antiretroviral treatment The South African Health Products Regulatory Authority (SAHPRA) has approved a sweet-tasting, heat-stable, ‘4-in-1’ fixed-dose…May 28, 2025
Dual therapy HIV treatment introduced in SA for the first time HIVPress Releases Dual therapy HIV treatment introduced in SA for the first time Two fixed-dose dual therapy antiretrovirals (ARVs) – a first in South Africa – for the…May 28, 2025
Cipla Launches #LIVE2LOVE Mobile Game to Educate and Destigmatise HIV Press ReleasesHIV Cipla Launches #LIVE2LOVE Mobile Game to Educate and Destigmatise HIV Global pharmaceutical company, Cipla, has launched the Live2Love mobile game, created to raise awareness around…May 27, 2025
Cipla wins portion of state ARV tender HIVPress Releases Cipla wins portion of state ARV tender Cipla, South Africa’s third largest pharmaceutical manufacturer, announced that it has been awarded a share…May 1, 2025